The State of Reconstructive Urology: Innovation, Evidence, and the Expanding Scope of Our Craft [0.03%]
重建泌尿外科的现状：创新、证据和我们技艺的发展方向
Boyd R Viers,Jay Simhan
Boyd R Viers
Reply to Kristoffer Mazanti Cold, Lars Konge, and Sarah Hjartbro Bube's Letter to the Editor re. Roessler N, Miszczyk M, Miyajima K, et al. Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review. Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2025.12.007 [0.03%]
答复Kristoffer Mazanti Cold、Lars Konge和Sarah Hjartbro关于Roessler N, Miszczyk M, Miyajima K等人。《利用人工智能进行泌尿系统癌症风险分层和结局预测：系统评价》来信欧洲泌尿外科杂志焦点刊在线发表。http://dx.doi.org/10.1016/j.euf.2025.12.007
Navid Roessler,Marcin Miszczyk,Pawel Rajwa et al.
Navid Roessler et al.
Cosimo De Nunzio,Riccardo Lombardo,Marcus J Drake
Cosimo De Nunzio
Postvoid residual (PVR) urine volume is widely used in the evaluation of patients with lower urinary tract symptoms (LUTS) and benign prostatic obstruction (BPO), yet its clinical role remains debated. This mini review critically appraises ...
Re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274 [0.03%]
里特尔手册，斯坦约翰内斯，巴伯尼尔等。WATER III：一项前瞻性的部分随机试验，比较水下消融治疗与经尿道激光前列腺剜除术治疗下尿路症状的效果。Eur Urol Focus 2026;12:266-274
Emre Karabay
Emre Karabay
Cosmetic Penile Enhancement Surgery and the Role of the Reconstructive Urologist [0.03%]
阴茎美容整形手术及泌尿科重建医师的作用
Abdullah Al-Mitwalli,Amr Moubasher,David J Ralph et al.
Abdullah Al-Mitwalli et al.
Cosmetic penile enhancement represents an expanding field characterized by increasing demand, limited evidence, and significant ethical complexity. Though reconstructive interventions remain essential in the management of anatomical and fun...
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial [0.03%]
前列腺癌放射性核素联合策略：AlphaBet试验启示
Louise Kostos,James P Buteau,Arun A Azad et al.
Louise Kostos et al.
The integration of [177Lu]Lu-prostate-specific membrane antigen (PSMA) therapy into the treatment paradigm for advanced prostate cancer has improved survival and quality of life; however, resistance and disease progression remain inevitable...
New Paradigms in Theranostics of Prostate Cancer: The Rise of α-Emitters and Next-generation Targets [0.03%]
前列腺癌诊疗新范式：α发射体和新一代靶标的崛起
Désirée Deandreis,Eric Deutsch
Désirée Deandreis
Radioligand therapy (RLT) with [177Lu]Lutetium-PSMA (prostate specific membrane antigen) has become a pillar of prostate cancer treatment; however, resistance and PSMA-negative disease remain as unmet needs. The α-emitting radionuclides re...
Michael S Hofman
Michael S Hofman
Lutetium-177 PSMA radioligand therapy (RLT) represents a paradigm shift in advanced prostate cancer care, establishing a precision oncology standard through its inherent theranostic capability. From a nuclear medicine perspective, its defin...
Avoiding Prostate Biopsy in Early Prostate Cancer Detection: From Liquid Biopsy to PSMA-PET [0.03%]
前列腺癌早期检测中避免前列腺穿刺：从液体活检到PSMA PET技术
Abdullah Al-Khanaty,David Hennes,Michael S Hofman et al.
Abdullah Al-Khanaty et al.
The role of prostate biopsy in early detection is increasingly being questioned in the era of advanced imaging. With the widespread adoption of multiparametric magnetic resonance imaging and the emergence of prostate-specific membrane antig...
Re: Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al. Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review. Eur Urol Focus 2025; S2405-4569(25)00362-1. In press. http://dx.doi.org/10.1016/j.euf.2025.12.007 [0.03%]
Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima等。《系统评价：利用人工智能进行泌尿系肿瘤风险分层和预后预测》欧洲泌尿外科聚焦2025；S2405-4569(25)00362-1. 在线发表。http://dx.doi.org/10.1016/j.euf.2025.12.007
Kristoffer Mazanti Cold,Lars Konge,Sarah Hjartbro Bube
Kristoffer Mazanti Cold